Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

BACKGROUND: This study aimed to explore the efficacy and safety of sintilimab combined with induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (HNSCC) patients. METHODS: A total of 163 patients were prospectively enrolled; 98 patients received IC only, and 65 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xia, Fang, Qigen, Du, Wei, Zhang, Xu, Dai, Liyuan, Qiao, Yongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157730/
https://www.ncbi.nlm.nih.gov/pubmed/34044810
http://dx.doi.org/10.1186/s12885-021-08373-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157730/
https://www.ncbi.nlm.nih.gov/pubmed/34044810
http://dx.doi.org/10.1186/s12885-021-08373-8

Ejemplares similares